Omnicare repurchases $52 million 3.75% convertibles in second quarter

By Tali Rackner

Norfolk, Va., July 23 – Omnicare, Inc. repurchased about $52 million of its 3.75% convertible senior subordinated notes due 2025 during the second quarter of 2014, according to a filing with the Securities and Exchange Commission.

The total purchase price was about $134 million in cash.

As of June 30, $80 million of the convertibles remain outstanding.

Omnicare is a Cincinnati-based provider of pharmaceutical services to patients and providers.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.